Safety and Efficacy of Rapamycin-Eluting Vertebral Stents in Patients With Symptomatic Extracranial Vertebral Artery Stenosis
Background and Purpose: Drug-eluting stents generally have superior performance to bare metal stents in the treatment of vertebral artery stenosis (VAS). This prospective, multicenter, and single-arm clinical trial was initiated to assess in-stent restenosis (ISR) and midterm outcome after rapamycin...
Guardado en:
Autores principales: | Gaoting Ma, Ligang Song, Ning Ma, Raynald, Jie Shuai, Wei Wu, Jieqing Wan, Zhenwei Zhao, Guangjian Li, Sen Yin, Shenghao Ding, Jiang Li, Baixue Jia, Xu Tong, Dapeng Mo, Feng Gao, Xuan Sun, Yiming Deng, Xiaochuan Huo, Wei Li, Kangning Chen, Zhongrong Miao |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2b5873288cfe47908a328992362e51e3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Comparison between a Bare–Metal Stents and Drug Eluting Stents in patients undergoing Percutaneous Coronary Intervention.
por: Khaled Alsayed
Publicado: (2020) -
High coronary calcium score and post-procedural CK-MB are noninvasive predictors of coronary stent restenosis
por: Lee JB, et al.
Publicado: (2017) -
Comparison of Drug-Coated Balloon Angioplasty vs. Drug-Eluting Stent Implantation for Drug-Eluting Stent Restenosis in the Routine Clinical Practice: A Meta-Analysis of Randomized Controlled Trials
por: Yong Zhu, et al.
Publicado: (2021) -
Long term safety and efficacy of the Yukon Choice Flex sirolimus-eluting coronary stent-a real-world data from India
por: Basant Kumar, et al.
Publicado: (2021) -
SÍNDROME CORONARIO AGUDO COMO MANIFESTACIÓN CLÍNICA DE LA REESTENOSIS INTRASTENT
por: Pérez,Luis, et al.
Publicado: (2013)